References
- Epstein S. Serum and urinary markers of bone remodelling: assessment of bone turnover. Endocr Rev 1988; 9: 437–49
- Stepán J J., Silinkova-Malkova E, Havranek T, et al. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin Chim Acta 1983; 133: 189–200
- Scarnecchia L, Minisola S, Pacitti M T., et al. Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 1991; 51: 517–24
- Stépán J J., Lachmanová J, Straková M, Pacovsky V. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis. Bone Miner 1987; 3: 177–83
- De la Piedra C, Torres R, Rapado A. Serum tartrate resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis. Calcif Tissue Int 1989; 45: 58–60
- Torres R, De la Píedra C, Rapado A. Clinical usefulness of serum tartrate-resistant acid phosphatases in Paget's disease of bone: correlation with other biochemical markers of bone remodelling. Calcif Tissues Int 1991; 49: 14–16
- Uebelhart D, Gineyts E, Chapuy M C., Delmas P D. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990; 8: 87–96
- Uebelhart D, Schlemmer A, Johansen J S., Gineyts E, Christiansen C, Delmas P D. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991; 72: 367–73
- Eriksen E F., Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I Collagen formation and degradation in metabolic bone disease: correlation with bone histomorpho-metry. J Bone Miner Res 1993; 8: 127–32
- Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635–40
- Stewart A F., Vignery A, Silvergate A. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab 1982; 55: 219–27
- Horiuchi N, Caufield M P., Fisher J E., et al. Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science 1987; 238: 1566–68
- Cohen Solal M E., Sebert J L., Boudailhez B, et al. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 1991; 73: 516–24
- Fredlund P E., Ockerman P A., Vancy J D. Disappearance of intravenously infused acid hydrolases from the circulation in pigs. Acta Chir Scand 1973; 139: 19–25